quantisnow
FeedTopReportsPricing
⌘K
Live feed
18:47:23·57d
INSIDERFiling
Personalis Inc. logo

SEC Form 4 filed by PRESIDENT AND CEO Hall Christopher M

PSNL· Personalis Inc.
Health Care
Original source

Companies

  • PSNL
    Personalis Inc.
    Health Care

Recent analyst ratings

  • Dec 2UpdateMorgan Stanley$11.00
  • May 15UpdateGuggenheim$6.00
  • Mar 17UpdateCanaccord Genuity$8.00
  • Feb 6UpdateNeedham$8.00
  • Feb 6UpdateNeedham-
  • Feb 25UpdateOppenheimer$24.00

Related

  • PR14h
    Personalis to Announce First Quarter 2026 Financial Results
  • PR3d
    Personalis Highlights Clinical Impact of Ultrasensitive ctDNA Monitoring and New Therapy Resistance Tracking at AACR 2026
  • PR11d
    Personalis and Collaborators to Highlight Ultrasensitive ctDNA Data and New Therapy Resistance Tracking Capabilities at AACR 2026
  • SEC21d
    SEC Form DEFA14A filed by Personalis Inc.
  • SEC21d
    SEC Form DEF 14A filed by Personalis Inc.
  • PR22d
    Personalis to Participate in the 25th Annual Needham Virtual Conference
  • INSIDER37d
    CFO AND COO Tachibana Aaron was granted 34,375 shares, increasing direct ownership by 21% to 198,833 units (SEC Form 4)
  • INSIDER37d
    SVP and Chief Legal Officer Moore Stephen Michael was granted 28,125 shares, increasing direct ownership by 44% to 92,325 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022